Craft

Tempus AI

Stock Price

$45.2

2024-10-29

Market Capitalization

$7 B

2024-10-29

Revenue

$1.3 B

FY, 2025

Tempus AI Summary

Company Summary

Overview
Tempus AI (formerly Tempus Labs) is a technology company that develops a data-driven precision medicine platform for the healthcare sector. It allows users to generate, collect, structure, and analyze genomic data. The company also provides genomic profiling, data collaboration, clinical trial matching, companion diagnostics, biological modeling, EHR integration, and other solutions.
Type
Public
Status
Active
Founded
2015
HQ
Chicago, IL, US | view all locations
Website
https://www.tempus.com/
Cybersecurity rating
Sectors

Key People

  • Eric Lefkofsky
  • Shane Colley

    Shane Colley, Chief Technology Officer

  • Jim Rogers

    Jim Rogers, Chief Financial Officer

  • Ryan Fukushima

    Ryan Fukushima, Chief Operating Officer

Operating MetricsView all

Samples Processed per Year (Infectious Diseases)

1M

May, 2020

Product Categories

5

May, 2020

Trademarks

14

May, 2020

LocationsView all

12 locations detected

  • Chicago, IL HQ

    United States

    600 West Chicago Avenue, Suite 510

  • Boston, MA

    United States

    33 Arch Street, Suite 16-126

  • Bothell, WA

    United States

    22121 17th Ave

  • Durham, NC

    United States

    25 Alexandria Way Suite 300

  • Lewisburg, PA

    United States

    434 Market Street, 2nd Floor

  • Milwaukee, WI

    United States

    411 E. Wisconsin Avenue, Suite 2299

and 6 others

Tempus AI Financials

Summary Financials

Revenue (Q1, 2026)
$348.1M
Net income (Q1, 2026)
($125.9M)
Cash (Q1, 2026)
$521.2M
EBIT (Q1, 2026)
($84.7M)
Enterprise value
$7.0B

Footer menu